Should beta-blockers still be recommended as first-line therapy for essential hypertension in younger patients?

  • LW Ng
  • CL Teng

Abstract

Mr. M is a 48 year-old male teacher who has had essentialhypertension for the past 2 years. He is a non-smoker and isnot diabetic. There is no family history of heart disease. Hisblood pressure is well-controlled at 129/78 mmHg (pulse rate60/min) with atenolol at 100mg daily. Clinically, there is notarget organ damage. He has heard that the use of betablockers in hypertension is now controversial and has askedif he should continue taking atenolol. (copied from article)

References

Messerli FH, Grossman E, Goldbourt U. Are ß-blockers efficacious as first-line therapy for hypertension in the elderly? A systemic review. JAMA. 1998;279(23):1903-7.

Lindholm LH, Carlberg B, Samuelsson O. Should ß blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005;366(9496):1545-53.

Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise choice? Lancet 2004;364(9446):1684-9.

Khan N, McAlister FA. Re-examining the efficacy of ß-blockers for the treatment of hypertension: a meta-analysis. CMAJ. 2006;174(12):1737-42.

Ong HT. What we really need to do to reduce cardiovascular events in hypertensive patients. J Fam Pract. 2007;56(9):727-34.

Published
2008-03-31
How to Cite
NgL., & TengC. (2008). Should beta-blockers still be recommended as first-line therapy for essential hypertension in younger patients?. Malaysian Family Physician, 3(1), 2. Retrieved from https://www.e-mfp.org/ojs3/index.php/MFP/article/view/277
Section
Original Articles